US 11136321
Tricyclic compounds
granted A61PA61P31/12A61P31/20
Quick answer
US patent 11136321 (Tricyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12, A61P31/20